JD Health International (FRA:8ZN) Shares Outstanding (Basic Average): 3,167 Mil (As of Dec. 2025)


FRA:8ZN JD Health International Inc FRA:8ZN
90 GF Score
Price €3.72
GF Value €6.38
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is JD Health International Shares Outstanding (Basic Average)?

JD Health International FRA:8ZN +1.61% 90 Shares Outstanding (Basic Average) is 3,167 Mil as of Dec. 2025. GuruFocus rates FRA:8ZN with a GF Score™ of 90/100 and a GF Value™ of €6.38 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. JD Health International's average basic shares outstanding for the quarter that ended in Dec. 2025 was 3,167 Mil.


JD Health International  (FRA:8ZN) Shares Outstanding (Basic Average) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.


Be Aware

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


JD Health International Shares Outstanding (Basic Average) Related Terms


JD Health International Shares Outstanding (Basic Average) Historical Data

* Premium members only.

The historical data trend for JD Health International's Shares Outstanding (Basic Average) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JD Health International Shares Outstanding (Basic Average) Chart

JD Health International Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (Basic Average)
Get a 7-Day Free Trial Premium Member Only 3,094.89 3,106.94 3,123.74 3,142.73 3,163.48

JD Health International Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Shares Outstanding (Basic Average) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,127.19 3,139.95 3,145.51 3,160.35 3,166.61
FRA:8ZN
90GF Score
JD Health International Inc FRA:8ZN
Shares Outstanding (Basic Average) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JD Health International Shares Outstanding (Basic Average) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that exact time point. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (Basic Average) of 3,167 Mil mean?
JD Health International (FRA:8ZN) has a Shares Outstanding (Basic Average) of 3,167 Mil as of Dec. 2025. The average shares outstanding over two periods not accounting for dilutive securities like convertible bonds. View historical data on JD Health International and its competitors.
Is JD Health International's Shares Outstanding (Basic Average) too high?
JD Health International's current Shares Outstanding (Basic Average) is 3,167 Mil. Overall, JD Health International has a GF Score™ of 90/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JD Health International's Shares Outstanding (Basic Average) compare to competitors?
JD Health International's Shares Outstanding (Basic Average) of 3,167 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (Basic Average) for a Healthcare Providers & Services company?
A good Shares Outstanding (Basic Average) depends on the Healthcare Providers & Services industry context. However, Shares Outstanding (Basic Average) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (Basic Average) mean?
A high Shares Outstanding (Basic Average) can signal that a stock is expensive relative to its fundamentals. The average shares outstanding over two periods not accounting for dilutive securities like convertible bonds. View historical data on JD Health International and its competitors. JD Health International's current Shares Outstanding (Basic Average) is 3,167 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JD Health International stock overvalued right now?
Based on GuruFocus' analysis, JD Health International (FRA:8ZN) is currently considered Significantly Undervalued. The stock's GF Value™ is €6.38, compared to a current price of €3.72 — trading 41.7% below its estimated fair value. The current Shares Outstanding (Basic Average) is 3,167 Mil. JD Health International's overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (Basic Average) calculated?
Shares Outstanding (Basic Average) is calculated from a company's financial statements. For JD Health International (FRA:8ZN), the current Shares Outstanding (Basic Average) is 3,167 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is JD Health International (FRA:8ZN) Overvalued in 2026?

Based on GuruFocus' analysis, JD Health International stock appears to be undervalued. The current stock price of €3.72 is trading 41.7% below its estimated GF Value™ of €6.38. GuruFocus considers JD Health International to be Significantly Undervalued.

Key valuation signals for FRA:8ZN:

  • Shares Outstanding (Basic Average): 3,167 Mil
  • GF Value™: €6.38 vs. price of €3.72 (41.7% below fair value)
  • GF Score™: 90/100 with 1 warning sign

No single metric tells the full story. See the FRA:8ZN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


JD Health International Business Description

Address No. 20 Kechuang 11 Street, Block C, Building 2, Jingdong Headquarters, Economic and Technological Development Zone, Daxing District, Beijing, CHN, 101111
JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health and Meituan for its e-commerce business. As of Dec. 31, 2024, the platform has over 200 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.
90GF Score

Get the complete analysis for FRA:8ZN

Shares Outstanding (Basic Average) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.72
Price
€6.38
GF Value